Biocardia announces pricing of $10 million public offering

San carlos, calif., june 17, 2020 (globe newswire) -- biocardia®, inc.  nasdaqcm: bcda (the “company”), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the pricing of its public offering of 4,762,000 shares of common stock at a price to the public of $2.10 per share. biocardia expects to receive gross proceeds of $10 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
BCDA Ratings Summary
BCDA Quant Ranking